Byrne Robert J
Known title: DirectorCIK: 0001580704
Associated companies
this person other insiders at XIFR
Transaction History
| XIFR | ▲ Buy | Grant | 14,740 | $0 | 2/9/2026 | View on chart |
| XIFR | ▲ Buy | Grant | 17,630 | $0 | 2/18/2025 | View on chart |
| XIFR | ▲ Buy | Grant | 5,290 | $0 | 2/20/2024 | View on chart |
| XIFR | ▲ Buy | Grant | 2,180 | $0 | 2/22/2023 | View on chart |
| XIFR | ▲ Buy | Grant | 2,010 | $0 | 2/22/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 15, 2026
Morgan Stanley Lowers XIFR Target to $11, Maintains Underweight
Morgan Stanley has kept an underweight stance on XIFR and cut its price target to $11. The firm cites concerns about the company’s free‑cash‑flow yield and dividend sustainability, which are highlighted in recent dividend‑focused articles. The downgrade comes as the stock trades near its 52‑week low and below the analyst average target of $12.09. Investors may want to review the company’s cash‑flow and dividend profile before making decisions.
Morgan Stanley Lowers XIFR Target to $11, Maintains Underweight. Morgan Stanley has kept an underweight stance on XIFR and cut its price target to $11. The firm cites concerns about the company’s free‑cash‑flow yield and dividend sustainability, which are highlighted in recent dividend‑focused articles. The downgrade comes as the stock trades near its 52‑week low and below the analyst average target of $12.09. Investors may want to review the company’s cash‑flow and dividend profile before making decisions.